# A Study to Measure Daridorexant in Breast Milk of Healthy Lactating Women

> **NCT05632393** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Daridorexant

## Key facts

- **NCT ID:** NCT05632393
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-16
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05632393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05632393, "A Study to Measure Daridorexant in Breast Milk of Healthy Lactating Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05632393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*